Jon Napitupulu

Alzamend Neuro partners with Massachusetts General Hospital, a renowned Harvard Medical School research facility, to conduct a groundbreaking Phase...

Summit Therapeutics‘ investigational bispecific antibody, Ivonescimab, has achieved clinically significant benefits in a Phase III trial (HARMONi-2) compared to...

Pfizer has reported positive results from a clinical trial evaluating its vaccine, ABRYSVO, in immunocompromised adults at risk of...

Blue Earth Therapeutics Expands Manufacturing Collaboration with Seibersdorf Labor Blue Earth Therapeutics, a subsidiary of Bracco, has expanded its...

After releasing unfavorable results from the Phase 2 portion of the EBO-301 study, AN2 Therapeutics has decided to cease...

Humanetics Corporation and researchers from the Armed Forces Radiobiology Research Institute (AFRRI) have partnered to secure $3 million in...

In partnership with Microsoft, Paige has introduced Virchow2 and Virchow2G, the latest generation of its AI foundation models for...

Tempus AI, a leading company in applying AI to precision medicine, has published a study validating its investigational human...

DeepCure, a biotechnology company leveraging AI for drug discovery, has unveiled its first development candidate, DC-9476. This third-generation BRD...

Cybin Inc., a clinical-stage neuropsychiatry company, reported its financial results for the first quarter ended June 30, 2024, and...